Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.

Trial Profile

Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Tibolone (Primary) ; Conjugated estrogens/medroxyprogesterone
  • Indications Menopausal syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2011 Actual initiation date (22 Dec 2006) added and additional lead trial centre identified as reported by Iranian Registry of Clinical Trials.
    • 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138809032766N1).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top